Log In
BCIQ
Print this Print this
 

OPM-3023

  Manage Alerts
Collapse Summary General Information
Company onepharm Research & Development GmbH
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPeriodontitis
Indication DetailsTreat periodontal bone loss; Treat periodontal disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/23/2009

Undisclosed

0

Undisclosed

Get a free BioCentury trial today